Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

BACKGROUND: Antimuscarinic agents are currently the predominant treatment option for the clinical management of the symptoms of overactive bladder (OAB). However, low rates of persistence with these agents highlight the need for novel, effective and better-tolerated oral pharmacological agents. Mira...

Descripción completa

Detalles Bibliográficos
Autores principales: Khullar, Vik, Cambronero, Javier, Angulo, Javier C, Wooning, Marianne, Blauwet, Mary Beth, Dorrepaal, Caroline, Martin, Nancy E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849064/
https://www.ncbi.nlm.nih.gov/pubmed/24047126
http://dx.doi.org/10.1186/1471-2490-13-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849064/
https://www.ncbi.nlm.nih.gov/pubmed/24047126
http://dx.doi.org/10.1186/1471-2490-13-45

Ejemplares similares